Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-09
1990-10-30
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546114, A61K 31435, C07D49504, C07D51304
Patent
active
049669044
ABSTRACT:
A compound of the formula (I) or its salt and a process for producing the compounds; The compounds have the effect to dilate neophrovascular tracts; ##STR1## Wherein ##STR2## represents the formula ##STR3## (wherein R.sup.4 is a hydrogen atom or lower alkylsulfonyl); R.sup.1 is hydrogen, lower alkyl, hydroxyl, halogen, amino, or lower acylamino;
REFERENCES:
patent: 4282227 (1981-08-01), Brenner
Fujikura Takashi
Tanaka Akihiro
Tsuzuki Ryuji
Yatsu Takeyuki
Yokota Masaki
Dentz Bernard I.
Lee Mary C.
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Substituted tetrahydroisoquinoline compounds, and process for pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydroisoquinoline compounds, and process for pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydroisoquinoline compounds, and process for pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-275445